Study Comparing 2 New Formulations of HKI-272 in Healthy Adult Subjects

Completed · Phase 1

Conditions studied: Healthy

In brief

To evaluate the comparative bioavailability of 2 new tablet formulations of HKI-272 with a reference capsule and an oral solution in healthy subjects.

Key facts

Study ID

NCT00498745

Run by

Puma Biotechnology, Inc.

People needed

36

Starts

2007-07-01

Expected to finish

2007-09-01

Last updated by the study team

2012-05-14

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

Where it is running

• Study site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.